The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis

被引：0
|
作者：
Aberer, Werner [1 ]
Maurer, Marcus [2 ]
Bouillet, Laurence [3 ]
Perrin, Amandine [4 ]
Zanichelli, Andrea [5 ]
Caballero, Teresa [6 ]
Longhurst, Hilary [7 ]
机构：
[1] Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria
[2] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany
[3] Grenoble Univ Hosp, Natl Reference Ctr Angioedema, Dept Internal Med, Grenoble, France
[4] Shire, Eysins, Switzerland
[5] Univ Milan, Dipartimento Sci Biomed & Clin, Osped Luigi Sacco, Milan, Italy
[6] Hosp La Paz Inst Hlth Res IdiPaz, Dept Allergy, Madrid, Spain
[7] Barts Hlth NHS Trust, London, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2014年 / 133卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2013.12.149
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
125
引用
收藏
页码：AB35 / AB35
页数：1
相关论文
共 50 条
  • [41] Hereditary angioedema: successful long-term oral prophylaxis with berotralstat
    Wedekind, Silke
    ALLERGO JOURNAL, 2022, 31 (06) : 123 - 123
  • [42] Hereditary angioedema: new data on long-term prophylaxis with berotralstat
    不详
    ALLERGO JOURNAL, 2023, 32 (07) : 71 - 71
  • [43] Clinical experience with Icatibant for treatment of acute attacks in patients with hereditary angioedema
    Oliveira Rodrigues do Valle, S.
    Tavares Franca, A.
    Afra Pires Levy, S.
    Malheiros, T.
    Mello, Y.
    Sarquis Serpa, F.
    Sevciovic Grumach, A.
    Albuquerque Campos, R.
    ALLERGY, 2012, 67 : 359 - 359
  • [44] Long-term Prophylaxis With C1-Inhibitor Concentrate in Patients With Hereditary Angioedema
    Pedrosa, M.
    Lobera, T.
    Panizo, C.
    Jurado, J.
    Caballero, T.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2014, 24 (04) : 271 - 273
  • [45] Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients
    Bork, Konrad
    Bygum, Anette
    Hardt, Jochen
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (02) : 153 - 161
  • [46] Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey
    Longhurst, H. J.
    Bouillet, L.
    Aberer, W.
    Caballero, T.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Maurer, M.
    ALLERGY, 2020, 75 : 209 - 209
  • [47] PHYSICIAN PERSPECTIVES ON LONG-TERM PROPHYLAXIS OF HEREDITARY ANGIOEDEMA: A PRAGMATIC REVIEW
    Beckerman, R.
    Barnes, D.
    Supina, D.
    Krishnarajah, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S40 - S40
  • [48] Value of long-term prophylaxis of hereditary angioedema: a review of physicians' recommendations
    Machnig, T.
    Beckerman, R.
    Chiao, J.
    Supina, D.
    Krishnarajah, G.
    ALLERGY, 2018, 73 : 611 - 611
  • [49] A new oral kallikrein inhibitor for long-term prophylaxis of hereditary angioedema
    Dona, Inmaculada
    Torres, Maria Jose
    ALLERGY, 2021, 76 (06) : 1619 - 1620
  • [50] PHYSICIAN PERSPECTIVES ON LONG-TERM PROPHYLAXIS OF HEREDITARY ANGIOEDEMA: A PRAGMATIC REVIEW
    Barrese, Giulio
    Gaw, James
    Giry-Laterriere, Marc
    Beckerman, Rachel
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 21 - 21
12345